Tower Research Capital LLC (TRC) - INVIVO THERAPEUTICS HLDGS CO ownership

INVIVO THERAPEUTICS HLDGS CO's ticker is and the CUSIP is 46186M506. A total of 24 filers reported holding INVIVO THERAPEUTICS HLDGS CO in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of INVIVO THERAPEUTICS HLDGS CO
ValueSharesWeighting
Q1 2022$3,000
-62.5%
9,945
-9.1%
0.00%
Q3 2021$8,00010,941
+4294.0%
0.00%
Q1 2021$0
-100.0%
249
-99.5%
0.00%
-100.0%
Q4 2020$37,00045,7780.00%
Other shareholders
INVIVO THERAPEUTICS HLDGS CO shareholders Q2 2021
NameSharesValueWeighting ↓
IMS Capital Management 20,146$7,0000.00%
VANGUARD GROUP INC 292,603$101,0000.00%
UBS Group AG 25,171$9,0000.00%
IFP Advisors, Inc 1$1,0000.00%
Sugarloaf Wealth Management, LLC 1$00.00%
OSAIC HOLDINGS, INC. 112$00.00%
BANK OF AMERICA CORP /DE/ 5$00.00%
WELLS FARGO & COMPANY/MN 212$00.00%
NORTHERN TRUST CORP 70,536$24,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of INVIVO THERAPEUTICS HLDGS CO shareholders